2017 Contracts Marketing Settlement 
LexBlog IP
APRIL 12, 2023
In 2017, three indirect-purchaser antitrust class actions were filed against Johnson & Johnson and Janssen Biotech, Inc., alleging that they engaged in anticompetitive conduct relating to the sale and marketing of J&J’s REMICADE (infliximab). The court preliminarily approved the settlement in August 2022.
43(B)log
MARCH 28, 2024
Princeton insured Wonderland from 2016-2018 (with a broad exclusion for defamation, invasion of privacy, and various forms of advertising injury in the second year called the Exhibitions and Related Marketing Exclusion), and agreed to defend the club but reserved the right to deny insurance coverage. about your goods, products or services”).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JIPEL Copyright Blog
DECEMBER 3, 2021
The policy requires franchise owners to engage in “good faith” efforts to remain in their current market. In 2017, the City of St. As the NFL and its franchise owners continue to exhaust avenues to avoid litigation and discovery, the January 10, 2022 trial date approaches, and the likelihood of a settlement in this case increases.
Biswajit Sarkar Copyright Blog
MAY 7, 2021
In today’s era, where the whole world has turned to virtual means, blockchain as a technology is gathering everyone’s attention and showing accelerating growth in its market. Most number of patents for blockchains were filed in the year 2017. to various entities dealing with the same.
Biswajit Sarkar Copyright Blog
MAY 7, 2021
In today’s era, where the whole world has turned to virtual means, blockchain as a technology is gathering everyone’s attention and showing accelerating growth in its market. Most number of patents for blockchains were filed in the year 2017. to various entities dealing with the same.
Biswajit Sarkar Copyright Blog
MAY 7, 2021
In today’s era, where the whole world has turned to virtual means, blockchain as a technology is gathering everyone’s attention and showing accelerating growth in its market. Most number of patents for blockchains were filed in the year 2017. to various entities dealing with the same.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. January 2021. off ASP and 23.7%
Expert insights. Personalized for you.
52 
Let's personalize your content